Release date:2020/5/9 4:38:51
Facebook Twitter LinkedIn




PEG Media of ADC Drugs

Antibody-drug Conjugates or ADCs are highly targeted biopharmaceutical drugs that combine monoclonal antibodies specific to surface antigens present on particular tumor cells with highly potent anti-cancer agents linked via a chemical linker. The linker plays a key role in determining the pharmacokinetic properties, therapeutic index, selectivity and the overall success of the ADC.


PEG-linkers are particularly attractive as a linker for conjugation. Water solubility, lack of toxicity; low immunogenicity and well defined chain lengths and molecular weights are specific characteristics of PEG moieties relevant to pharmaceutical applications.


Biochempeg develops a broad range of PEG linkers and provides custom linker synthesis for clients worldwide.

Featured PEG Linkers

I'm an image


CAS NO.: 2182602-17-9

I'm an image

N-(Azido-PEG3)-N-Bis-(PEG3-t-butyl ester)

CAS NO.: 2055042-56-1

I'm an image

Mal-PEG8-NHS ester

CAS NO.: 2055033-05-9

I'm an image

Mal-PEG1-NHS ester

CAS NO.: 1807518-72-4


Biochempeg Scientific Inc. 

Add:108 Water Street, Room 4D, Watertown, MA 02472, USA

Phone: +1-857-366-6766 Fax: +1-617-206-9595


Previous:Raw Material for Semaglutide Side Chain Next:Click Chemistry Reagents - Azide, Alkyne, DBCO, BCN PEG Products from Biochempeg